Home > Insider Trading > Filing (0001816590-24-000052)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1816590	Compass Pathways Plc	CMPS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1843859	Jay George Goldsmith	Compass Pathways Plc 33 Broadwick Street London X0 W1F 0DQ		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2024-03-12	15,740	$10.58	4,079,107	No	4	S	Direct
Ordinary Shares	Disposition	2024-03-12	15,740	$10.58	4,076,833	No	4	S	Indirect	By: Spouse
Ordinary Shares	Disposition	2024-03-13	17,203	$10.80	4,061,904	No	4	S	Direct
Ordinary Shares	Disposition	2024-03-13	17,203	$10.80	4,059,630	No	4	S	Indirect	By: Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	By: Spouse
No	4	S	Direct
No	4	S	Indirect	By: Spouse

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Goldsmith on August 23, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.36 to $10.765, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Dr. Malievskaia on August 23, 2023.
Securities held by Dr. Ekaterina Malievskaia, the Reporting Person's spouse. Dr. Malievskaia and Mr. Goldsmith are married but they expressly disclaim beneficial ownership of each other's shares in the Issuer.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.65 to $11.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.